Bugao, Lita L.

HRN: 02-15-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/21/2025
01/28/2025
IV
2.25gms
Q8
CAP MR
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines